C12Y 207/01149
1-phosphatidylinositol-5-phosphate 4-kinase
Official title: 1-Phosphatidylinositol-5-phosphate 4-kinase (2.7.1.149)
C12Y207/01149 (1-phosphatidylinositol-5-phosphate 4-kinase) appears on 0 US grants and 4 published applications in this corpus.
Search patents in C12Y- Granted patents
- 0
- Published applications
- 4
- Assignees
- 4
- Inventors
- 9
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2022 | 0 | 2 |
| 2023 | 0 | 1 |
| 2024 | 0 | 1 |
By publication year.
Recent patents
No granted patents in this class yet.
- Loss of lipid kinase pi5p4k gamma restricts tumor growth23 May 2024US 2024/0167041 A1Cornell University
- Methods of controlling bodyweight by modulating phosphatidylinositol 5-phosphate 4-kinase beta activity30 Mar 2023US 2023/0096781 A1University of Cincinnati
- Gene delivery systems for treatment of heart failure3 Nov 2022US 2022/0347204 A1Icahn School of Medicine at Mount Sinai
- Pip4ks suppress insulin signaling and enhance immune function through a catalytic-independent mechanism2 Jun 2022US 2022/0168402 A1Cornell University
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.